GL1X · GenesisL1 explorer

MolNFT v1 · #115036 · protein

Structure of human testis-specific glyceraldehyde-3-phosphate dehydrogenase holo form with NAD+

5C7O · Glyceraldehyde-3-phosphate dehydrogenase, testis-specific: “Structure of human testis-specific glyceraldehyde-3-phosphate dehydrogenase holo form with NAD+”. X-ray diffraction, 2 ligands (NAD, SO4), 3 pockets (best druggability…

PDB
5C7O
Type
protein
Length
670 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glyceraldehyde-3-phosphate dehydrogenase, testis-specific
EC
1.2.1.12
UniProt
O14556
Ligands
NAD, SO4
Pockets
3 · best druggability 0.65

Structure

x-ray diffraction · 1 distinct chain · 32% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
O, PGlyceraldehyde-3-phosphate dehydrogenase, testis-specific (EC 1.2.1.12)protein33532% helix, 27% strandO14556

Ligands and binding sites

  • NAD · Nicotinamide-adenine-dinucleotide · ligand · 2 copies · chains O, P
  • SO4 · Sulfate ion · ion · 2 copies · chains O, P

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15500.650.7766NAD, SO4
24830.630.7648NAD, SO4
3610.300.7517empty

Interfaces

1 interface between chains.

  • O–P · 2016 Ų buried · 30 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (oxidation).

Compared structures

  • 5C7O · Structure of human testis-specific glyceraldehyde-3-phosphate dehydrogenase holo form… · the same entry in another collection · chain O against O, TM-score 1.00
  • O14556 · AlphaFold monomer V2.0 prediction for glyceraldehyde-3-phosphate dehydrogenase… · a predicted model of the same protein · chain P against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.